OpenEvidence provides verified U.S. healthcare professionals with a centralized platform for accessing multimedia and clinical findings from leading medical publications. The service aggregates essential resources, including content from The New England Journal of Medicine, JAMA Network journals, and Cochrane systematic reviews. This platform ensures rapid access to high-quality, synthesized medical evidence for clinical decision support.
Funding
$60.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
+1Founders
Product
Problem
Medical professionals face an overwhelming amount of research published annually, making it difficult to stay current with the latest clinical evidence and best practices. This information overload can hinder evidence-based decision-making and negatively impact patient outcomes.
Solution
OpenEvidence is an AI-powered medical information platform designed to aggregate, synthesize, and visualize clinically relevant evidence in accessible formats. By partnering with leading medical journals such as The New England Journal of Medicine and JAMA Network, OpenEvidence provides healthcare professionals with a comprehensive resource for up-to-date medical knowledge. The platform employs AI algorithms to streamline access to critical information, enabling informed decisions and improved patient care. OpenEvidence aims to tame the medical information firehose, ensuring that healthcare providers can efficiently monitor and understand the latest research literature.
Target Audience
The primary users are physicians, medical researchers, and healthcare professionals seeking to improve evidence-based decision-making and patient outcomes.
Features
- AI-driven aggregation and synthesis of medical research from leading journals
- Multimedia presentation of clinical findings for enhanced understanding
- Evidence-based insights presented in accessible and understandable formats
- Personalized feed to stay up-to-date on the latest findings
- Mobile-friendly platform for on-the-go access